公开(公告)号：US20060149487A1

公开(公告)日：2006-07-06

申请号：US11025097

申请日：2004-12-29

申请人： Jeffrey Fry ,  Lori Cross ,  Arthur Hauck

发明人： Jeffrey Fry ,  Lori Cross ,  Arthur Hauck

IPC分类号： G06F19/00

CPC分类号： G16H10/40

摘要： The present invention relates to a method and system for suspending the processing of laboratory test results in a computerized environment. One or more test results from an instrument in a healthcare laboratory are received. It is determined whether the instrument has had a quality control procedure performed within a predefined period. If not, the processing of the one or more test results is suspended until the quality control procedure has been performed on the instrument. If the quality control procedure has been performed within the predefined period, it is determined whether the quality control procedure performed indicates that the instrument is performing properly. If not, the processing of the one or more test results is suspended until the quality control issue is resolved.

摘要翻译： 本发明涉及一种在计算机化环境中暂停实验室测试结果处理的方法和系统。 收到医疗保健实验室仪器的一个或多个测试结果。 确定仪器是否在预定义的时间内执行了质量控制程序。 如果不是，一个或多个测试结果的处理被暂停，直到对仪器执行质量控制程序。 如果在预定义的时间内已经执行了质量控制程序，则确定所执行的质量控制程序是否表明仪器正在执行。 如果不是，一个或多个测试结果的处理被暂停，直到质量控制问题得到解决。

公开(公告)号：US20060136137A1

公开(公告)日：2006-06-22

申请号：US11018660

申请日：2004-12-21

申请人： Arthur Hauck ,  Lori Cross ,  Jeffrey Fry

发明人： Arthur Hauck ,  Lori Cross ,  Jeffrey Fry

IPC分类号： G06F19/00

CPC分类号： G06F19/3456 ,  G06F19/00 ,  G06Q50/24

摘要： The present invention relates to a system and method for safely transfusing blood to a patient in a computerized healthcare environment is provided. A blood product to be administered to a patient is identified and the patient is identified. A database containing a plurality of blood compatibility test results is accessed and it is determined whether the database contains a blood compatibility test result for the identified blood product and identified patient. If so, it is determined whether the test result indicates that the identified blood product is compatible for the identified patient.

摘要翻译： 本发明涉及一种用于在计算机化医疗环境中将血液安全地输送给患者的系统和方法。 鉴定要给予患者的血液制品并鉴定患者。 访问包含多个血液兼容性测试结果的数据库，并且确定数据库是否包含所识别的血液产品和识别的患者的血液兼容性测试结果。 如果是，确定测试结果是否表明所鉴定的血液产品与所识别的患者是兼容的。

公开(公告)号：US20060178909A1

公开(公告)日：2006-08-10

申请号：US11018160

申请日：2004-12-21

申请人： Arthur Hauck ,  Lori Cross ,  Jeffrey Fry

发明人： Arthur Hauck ,  Lori Cross ,  Jeffrey Fry

IPC分类号： G06F19/00

CPC分类号： G06Q50/24 ,  G06F19/3481 ,  G06Q10/087 ,  G06Q50/22 ,  G16H40/20

摘要： The present invention relates to a method for automatically tracking blood product administration in a computerized healthcare environment. Information regarding a blood product unit received by the blood bank department is documented in a database. An indication that the blood product unit has been administered to the patient by a healthcare provider is received and the database is automatically updated to reflect that the blood product unit has been administered to the patient. The present invention also relates to a method for automatically notifying a blood bank database of administration of a blood product to a patient in a computerized healthcare environment is provided

摘要翻译： 本发明涉及一种在计算机化医疗环境中自动跟踪血液制品管理的方法。 有关由血库部门接收的血液制品单元的信息记录在数据库中。 接收到由医疗保健提供者向患者施用血液制品单元的指示，并自动更新数据库以反映血液产品单元已被施用给患者。 本发明还涉及一种用于在计算机化医疗环境中自动通知血库数据库给患者的血液制品的方法

公开(公告)号：US20060149588A1

公开(公告)日：2006-07-06

申请号：US11025096

申请日：2004-12-29

申请人： Arthur Hauck ,  Lori Cross ,  Jeffrey Fry

发明人： Arthur Hauck ,  Lori Cross ,  Jeffrey Fry

IPC分类号： G06Q10/00

CPC分类号： A61M1/02 ,  A61B5/02055 ,  A61M5/1723 ,  A61M2205/6009 ,  A61M2205/6072 ,  G06F19/00 ,  G06F19/3481 ,  G06Q50/22 ,  G06Q50/24 ,  G16H10/40 ,  G16H10/60

摘要： A computerized system and method for processing patient vital signs during blood product administration in a computerized healthcare environment is provided. A blood product to be administered to a patient is identified. The patient is identified. Vital signs for the patient are received during blood product administration by a healthcare provider and automatically, without user intervention, the vital signs for the patient are documented in a database.

摘要翻译： 提供了一种用于在计算机化医疗环境中的血液制品管理期间处理患者生命体征的计算机化系统和方法。 鉴定要给予患者的血液制品。 确定患者。 在医疗保健提供者的血液制品管理期间接收患者的生命体征，并且在没有用户干预的情况下自动地将患者的生命体征记录在数据库中。

公开(公告)号：US20060136263A1

公开(公告)日：2006-06-22

申请号：US11021878

申请日：2004-12-22

申请人： Jeffrey Fry ,  Lori Cross ,  Arthur Hauck

发明人： Jeffrey Fry ,  Lori Cross ,  Arthur Hauck

IPC分类号： G06Q10/00 ,  A61B5/00

CPC分类号： G06Q50/22 ,  G06F19/00 ,  G06Q10/10

摘要： The present invention relates to a method of holding laboratory test results in a computerized environment. The method receives a laboratory test result for a healthcare order for a patient. The healthcare order comprises multiple laboratory tests. The method determines whether all of the test results for the healthcare order have been received. If all of the test results for the healthcare order have not been received, the laboratory test result is held until all of the results for the healthcare order have been received. If all of the results for the healthcare order have been received, the method compares each test result of the healthcare order to predefined criteria to determine whether each test result for the healthcare order is within a predetermined acceptable range. If each of the test results for the healthcare order is within the acceptable range, the entire order is automatically verified.

摘要翻译： 本发明涉及在计算机化环境中保持实验室测试结果的方法。 该方法获得患者医疗保健订单的实验室测试结果。 医疗保健单包括多个实验室检测。 该方法确定是否已收到医疗保健单的所有测试结果。 如果没有收到医疗保健单的所有测试结果，实验室测试结果将一直持续到医疗保健单的所有结果都已收到。 如果已经接收到医疗保健单的所有结果，则该方法将医疗保健单的每个测试结果与预定义的标准进行比较，以确定医疗保健订单的每个测试结果是否在预定的可接受范围内。 如果医疗保健单的每个测试结果都在可接受的范围内，则整个订单将自动验证。

公开(公告)号：US20050148033A1

公开(公告)日：2005-07-07

申请号：US11027307

申请日：2004-12-30

申请人： Lori Cross ,  Jeffrey Fry ,  Arthur Hauck

发明人： Lori Cross ,  Jeffrey Fry ,  Arthur Hauck

IPC分类号： A61M31/00 ,  C12Q1/68 ,  G01N33/49 ,  G01N33/555 ,  G01N33/567

CPC分类号： G01N33/49 ,  A61B5/15003 ,  A61B5/150221 ,  A61B5/150366 ,  A61B5/150992 ,  A61B5/155

摘要： The invention relates to a method and device for testing a blood product and a patient's blood immediately prior to transfusing the blood product to the patient. The device comprises a testing chamber within which the blood product and the patient blood are drawn and tested for compatibility. A first end of the testing chamber is coupled with an infusion needle in communication with the patient. A second end of the testing chamber is in fluid communication with the container housing the blood product. In an embodiment, blood product and patient blood are drawn into the testing chamber. One of a number of tests for determining blood compatibility is performed in the testing chamber. If the blood product and patient blood are compatible, blood product is delivered to the patient through a transfusion line bypassing the testing chamber.

摘要翻译： 本发明涉及一种用于在血液产品输入患者之前立即测试血液制品和患者血液的方法和装置。 该装置包括测试室，血液制品和患者血液在该测试室内被拉伸并测试其兼容性。 测试室的第一端与与患者通信的输注针联接。 测试室的第二端与容纳血液制品的容器流体连通。 在一个实施例中，血液制品和患者血液被吸入测试室。 在测试室中进行多种测定血液相容性的测试之一。 如果血液制品和患者血液是相容的，血液产品通过绕过测试室的输血管道输送给患者。

公开(公告)号：US08504391B2

公开(公告)日：2013-08-06

申请号：US12651112

申请日：2009-12-31

申请人： Chad Barrett Ruoff ,  Hugh Ryan ,  Lori Cross

发明人： Chad Barrett Ruoff ,  Hugh Ryan ,  Lori Cross

IPC分类号： G06Q10/00 ,  G06Q50/00

CPC分类号： G06Q50/22 ,  G06F19/00 ,  G16H50/20

摘要： Invoking of one or more clinical orders for a particular patient is driven by an infection risk stratification. According to an associated method, infection risk factors for a patient are assessed. The method also includes determining correlations between patient data and two or more particular categories of infection risk associated with the infection risk factors, stratifying infection risk for the patient based on the correlations determined, and determining specific clinical orders relevant for the particular patient based on the stratification.

摘要翻译： 为特定患者调用一个或多个临床订单是由感染风险分层驱动的。 根据相关方法评估患者的感染危险因素。 该方法还包括确定患者数据与与感染危险因素相关联的两个或多个特定类别的感染风险之间的相关性，基于所确定的相关性来分层患者的感染风险，以及基于所述特定患者确定与特定患者相关的特定临床指令 分层。